A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis (Q33897070)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis |
scientific article |
Statements
1 reference
A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis (English)
1 reference
Hagop Kantarjian
1 reference
Srdan Verstovsek
1 reference
William Wierda
1 reference
Jorge Cortes
1 reference
Tapan Kadia
1 reference
Farhad Ravandi
1 reference
Guillermo Garcia-Manero
1 reference
James Foran
1 reference
Jan Burger
1 reference
Gautham Borthakur
1 reference
Murray Yule
1 reference
Gillian Langford
1 reference
John Lyons
1 reference
John Ayrton
1 reference
Victoria Lock
1 reference
14 November 2013
1 reference
1 reference
14
1 reference
223-230
1 reference
Identifiers
1 reference
1 reference
1 reference